Purchases and Sales Made in Q4 2023 in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during Q4 2023. The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-38.7K- 43.77% |
$31K - $49.5K
|
49.7K
$183K
|
|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-38.9K- 28.06% |
$31.1K - $49.7K
|
99.6K
$368K
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-45.9K- 6.99% |
$36.7K - $58.8K
|
611K
$2.25M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-89.6K- 11.73% |
$71.6K - $115K
|
674K
$2.49M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-94.6K- 99.76% |
$75.7K - $121K
|
231
$852
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-98.3K- 99.77% |
$78.7K - $126K
|
231
$852
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-98.6K- 10.22% |
$78.9K - $126K
|
867K
$3.2M
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-308K- 4.26% |
$246K - $394K
|
6.92M
$25.5M
|
|
|
Mar 13, 2025
Q4 2023
|
Pko Investment Management Joint Stock CO
Warsaw, R9 |
SELL
|
- |
-548KClosed |
$439K - $702K
|
0
$0
|
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
SELL
|
- |
-733K- 97.02% |
$586K - $938K
|
22.5K
$83.1K
|